Cargando…

Can mRNA COVID‐19 vaccines induce flares of chronic urticaria?

Detalles Bibliográficos
Autores principales:	Kanokrungsee, Silada, Naruenatwanich, Chananchida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Covid Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874535/ https://www.ncbi.nlm.nih.gov/pubmed/36219543 http://dx.doi.org/10.1111/jocd.15443

Ejemplares similares

WCN23-0359 RENAL FLARE IN ADOLESCENTS WITH LUPUS NEPHRITIS RECEIVED COVID-19 mRNA VACCINE
por: THEPVEERA, S., et al.
Publicado: (2023)

Safety of COVID-19 mRNA vaccination in children with chronic urticaria
por: Zhu, Catherine K., et al.
Publicado: (2023)

COVID-19 Vaccine Induced Flares of Chronic Spontaneous Urticaria: A Case Series
por: Smee, Madeleine, et al.
Publicado: (2022)

Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines
por: Risma, Kimberly A., et al.
Publicado: (2021)

Shingles and mRNA COVID‐19 vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine
por: Saito, Kazuyuki, et al.
Publicado: (2021)

Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination
por: Yagi, Yohsuke, et al.
Publicado: (2021)

Clinicopathological features of cutaneous reactions after mRNA‐based COVID‐19 vaccines
por: Tihy, M., et al.
Publicado: (2021)

Humoral response to mRNA‐based COVID‐19 vaccine in patients with myeloid malignancies
por: Mori, Akio, et al.
Publicado: (2022)

Antibody responses to mRNA versus non-mRNA COVID vaccines among the Mongolian population
por: Sereejav, Enkhbold, et al.
Publicado: (2023)

The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning?
por: Jhaveri, Ravi
Publicado: (2021)

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
por: van Leeuwen, Leanne P.M., et al.
Publicado: (2022)

A case of anti-MOG antibody-positive ADEM following COVID-19 mRNA vaccination
por: Miyamoto, Katsuichi, et al.
Publicado: (2022)

Spinal cord ischemia complicating BNT162b2 mRNA COVID-19 vaccination
por: Fotiadou, Aggeliki, et al.
Publicado: (2022)

The ‘Pantie’ Tumour
por: Kanokrungsee, Silada, et al.
Publicado: (2014)

Cardiac magnetic resonance characteristics of acute myocarditis occurring after mRNA-based COVID-19 vaccines immunization
por: Meyer-Szary, Jaroslaw, et al.
Publicado: (2022)

Can COVID-19 vaccinations cause chronic urticaria?
por: Chu, Stacey, et al.
Publicado: (2023)

mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
por: Rama, Tiago Azenha, et al.
Publicado: (2021)

Urticarial and Eczematous Eruptions Following mRNA COVID-19 Vaccination in Patients With and Without Chronic Urticaria and Atopic Dermatitis
por: Shah, Ruchi, et al.
Publicado: (2022)

Fractional Carbon Dioxide Laser for Keratosis Pilaris: A Single-Blind, Randomized, Comparative Study
por: Vachiramon, Vasanop, et al.
Publicado: (2016)

High Prevalence of Hypovitaminosis D in Cutaneous and Systemic Lupus Erythematosus Patients and Its Associated Factors: A Cross-Sectional Study in Thailand
por: Kanokrungsee, Silada, et al.
Publicado: (2022)

Herpes zoster and alopecia areata following mRNA BNT162b2 COVID‐19 vaccine: Controversial immune effects
por: Martora, Fabrizio, et al.
Publicado: (2022)

Urticaria relapse after mRNA COVID‐19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single‐center experience
por: Picone, Vincenzo, et al.
Publicado: (2022)

Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
por: Altieri, Manuela, et al.
Publicado: (2022)

COV-BT Ire study: safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with brain tumors
por: Tanzilli, Antonio, et al.
Publicado: (2022)

Delayed urticaria after the third dose of mRNA COVID19 vaccine: A case series
por: Bianchi, Leonardo, et al.
Publicado: (2022)

New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series
por: Fanella, Gaia, et al.
Publicado: (2022)

A CASE SERIES: CHRONIC INDUCIBLE URTICARIA FOLLOWING COVID-19 INFECTION AND MRNA VACCINE
por: Hellu, T., et al.
Publicado: (2022)

Heterologous prime-boost with the mRNA-1273 vaccine among CoronaVac-vaccinated healthcare workers in Indonesia
por: Santi, Theresia, et al.
Publicado: (2022)

Clinical and immunological data from chronic urticaria onset after mRNA SARS‐CoV‐2 vaccines
por: Pescosolido, Eva, et al.
Publicado: (2022)

Factors Contributing to Long-Term Severe Visual Impairment in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Jongkhajornpong, Passara, et al.
Publicado: (2017)

A Comparison of Azathioprine and Mycophenolate Mofetil as Adjuvant Drugs in Patients with Pemphigus: A Retrospective Cohort Study
por: Sukanjanapong, Siriorn, et al.
Publicado: (2019)

First manifestation of AQP4-IgG-positive neuromyelitis optica spectrum disorder following the COVID-19 mRNA vaccine BNT162b2
por: Umezawa, Shu, et al.
Publicado: (2022)

Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab
por: Gallo, Antonio, et al.
Publicado: (2021)

mRNA-1273: Primary membranous nephropathy flare: case report
Publicado: (2021)

mRNA-1273: IgA nephropathy flare: case report
Publicado: (2021)

Autoimmune Rheumatic Disease Flares with Myocarditis Following COVID-19 mRNA Vaccination: A Case-Based Review
por: Lai, Yi Wye, et al.
Publicado: (2022)

Bacillus Calmette–Guérin scar flare after an mRNA SARS-CoV-2 vaccine
por: Lim, Darren Wan-Teck, et al.
Publicado: (2021)

Severity of adverse reactions is associated with T-cell response in mRNA-1273 vaccinated health care workers
por: Klingel, Hanna, et al.
Publicado: (2022)

Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia
por: Harrington, Patrick, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l0b0nj75c002v00ic06rpefinm